Followers | 1076 |
Posts | 80512 |
Boards Moderated | 6 |
Alias Born | 03/10/2009 |
Monday, June 14, 2021 8:07:21 AM
STOP & VISIT MY BOARD AT: HOTTEST PENNY STOCK PICKS
http://investorshub.advfn.com/boards/board.aspx?board_id=19627
My posts are NOT a buy/sell recommendation, Do your Own DD, before you buy any stock - I reserve the right to buy/sell any stock
Recent ITOS News
- Form 8-K - Current report • Edgar (US Regulatory) • 11/04/2024 12:00:08 PM
- iTeos Therapeutics to Highlight Inupadenant Preclinical, Translational, and Phase 2 A2A-005 Clinical Trial Data in 2L NSCLC at ESMO Immuno-Oncology Congress • GlobeNewswire Inc. • 10/24/2024 11:00:00 AM
- Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend] • Edgar (US Regulatory) • 10/21/2024 08:11:30 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/16/2024 11:00:12 AM
- iTeos Announces Clinically Meaningful Objective Response Rate Observed at Every Dose in Follow-up Interim Analysis of GALAXIES Lung-201 Study of Belrestotug + Dostarlimab in First-Line, PD-L1 High Non-Small Cell Lung Cancer Patients • GlobeNewswire Inc. • 09/14/2024 06:30:00 AM
- iTeos to Participate in Upcoming Investor Conferences • GlobeNewswire Inc. • 08/28/2024 08:30:00 PM
- iTeos Therapeutics Announces Late-Breaking Oral Presentation of Phase 2 GALAXIES Lung-201 Interim Data at the European Society for Medical Oncology Congress 2024 • GlobeNewswire Inc. • 08/20/2024 12:30:55 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/10/2024 12:00:02 AM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/08/2024 11:08:34 AM
- iTeos Reports Second Quarter 2024 Financial Results and Provides Business Updates • GlobeNewswire Inc. • 08/08/2024 11:00:00 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/05/2024 11:19:05 AM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 08/05/2024 11:16:38 AM
- iTeos Therapeutics Announces Appointment of David Feltquate as Chief Medical Officer • GlobeNewswire Inc. • 08/05/2024 11:00:00 AM
- iTeos Announces First Patient Dosed in GALAXIES Lung-301 Phase 3 Study, Earning $35 Million in Milestones from GSK • GlobeNewswire Inc. • 07/08/2024 11:00:00 AM
- iTeos and GSK Initiate GALAXIES Lung-301 Phase 3 Study, Assessing Belrestotug and Dostarlimab in Previously Untreated, Unresectable Locally Advanced / Metastatic PD-L1 Selected Non-Small Cell Lung Cancer • GlobeNewswire Inc. • 06/17/2024 01:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/14/2024 12:00:12 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/14/2024 12:00:10 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/14/2024 12:00:06 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/13/2024 08:01:10 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/13/2024 11:01:07 AM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 05/10/2024 08:35:07 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/10/2024 12:31:32 PM
- iTeos Reports First Quarter 2024 Financial Results and Provides Business Updates • GlobeNewswire Inc. • 05/10/2024 12:26:01 PM
- iTeos Therapeutics Announces $120 Million Registered Direct Offering • GlobeNewswire Inc. • 05/10/2024 12:24:05 PM
- iTeos Presents EOS-984 Preclinical Data Demonstrating Restoration of T Cell Activity from Adenosine Suppression at the American Association for Cancer Research Annual Meeting 2024 • GlobeNewswire Inc. • 04/07/2024 08:30:00 PM
FEATURED North Bay Resources Announces Assays up to 9.5% Copper at Murex Copper Project, British Columbia • Nov 4, 2024 9:00 AM
Rainmaker Worldwide Inc. Announces Strategic Partnership Between Miranda Water Technologies and Fleming College • RAKR • Nov 4, 2024 12:03 PM
Rainmaker Worldwide Inc. to Assume Direct, Non-Dealer Sales of Miranda Water Technologies in U.S. and Mexico in First Quarter of 2025 • RAKR • Nov 4, 2024 8:31 AM
CBD Life Sciences Inc. (CBDL) Launches High-Demand Mushroom Gummy Line for Targeted Wellness Needs, Tapping into a Booming $20 Billion Market • CBDL • Oct 31, 2024 8:00 AM
Nerds On Site Announces Q1 Growth and New Initiatives for the Remainder of 2024 • NOSUF • Oct 31, 2024 7:01 AM
Innovation Beverage Group Receives Largest Shipment of its Top-Selling Bitters to Date in the U.S.-Ready to Meet Growing Demand from Expanding Distribution Network • IBG • Oct 30, 2024 12:22 PM